Shares of Bio-Techne Corp. TECH shed 2.04% to $58.73 Friday, on what proved to be an all-around poor trading session for the ...

Let’s dig into the relative performance of Bio-Techne (NASDAQ:TECH) and its peers as we unravel the now-completed Q4 research ...

Bio-Techne Corporation (NASDAQ: TECH) today announced further advancements in its ongoing strategy to bring translational discoveries to patient care by leveraging RNAscope technology to address unmet ...

Shares of Bio-Techne Corp. TECH slipped 1.78% to $59.98 Tuesday, on what proved to be an all-around favorable trading session ...

Bio-Techne Corporation today announced it will open a new Customer Experience Centre in Düsseldorf, Germany to serve customers across the Europe, Middle East and Africa (EMEA) region and support the ...

Corporation announced further advancements in its ongoing strategy to bring translational discoveries to patient care by ...

Fintel reports that on March 18, 2025, Evercore ISI Group initiated coverage of Bio-Techne (NasdaqGS:TECH) with a Outperform ...

Proficio Capital Partners LLC increased its position in shares of Bio-Techne Co. (NASDAQ:TECH – Free Report) by 13.6% in the 4th quarter, according to its most recent disclosure with the SEC. The ...

Learn more about whether Repligen Corporation or Bio-Techne Corporation is a better investment based on AAII's A+ Investor ...

Equities research analysts at Evercore ISI assumed coverage on shares of Bio-Techne (NASDAQ:TECH – Get Free Report) in a ...

Bio-Techne's shares have been pressured lately on concerns about the academic research market and biopharma R&D restructuring, but core business trends look largely intact. Fiscal Q2 showed ...

In the preceding three months, 6 analysts have released ratings for Bio-Techne TECH, presenting a wide array of perspectives from bullish to bearish. The following table encapsulates their recent ...